January 28, 2023
0 0
Read Time:15 Second

The Food & Drug Administration have approved Eisai’s Alzheimer’s drug Leqembi. The drug is a breakthrough drug which is used to slow down cognitive decline in the early stage of the disease. It is expected to cost in the mid $20,000 range for a year’s worth of treatments.

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published.